इस एपिसोड के बारे में
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the emerging role of antibody-drug conjugates (ADCs) in the treatment of patients with non-small cell lung cancer (NSCLC), including the mechanistic rationale and role of biomarkers in patient selection, the latest efficacy and safety data, and dose-finding strategies for optimal use in NSCLC.
The experts:
- Prof. Jarushka Naidoo, Beaumont RCSI Cancer Centre, Dublin, Ireland
- Dr Rebecca Heist, Massachusetts General Hospital Cancer Center, Boston, MA, USA
- Dr Antonio Passaro, European Institute of Oncology, Milan, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is provided by touchIME.
For further information please visit: https://touchoncology.com/education/pd-navigating-the-nsclc-treatment-pathway-focus-on-adcs/
अंग्रेज़ी
संयुक्त राज्य अमरीका
अनुलिपि 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
पिछले एपिसोड्स खोजें
touchPODCAST के पिछले एपिसोड खोजें।
इस पॉडकास्ट के अन्य एपिसोड
touchPANEL DISCUSSION for touchNEUROLOGY
Hear from three experts as they share practical insights into recognizing and diagnosing Lennox–Gastaut syndrome across the lifespan, navigating the complexities of polytherapy, and addressing the cognitive, behavioral, functional, and quality of life chall…
touchEXPERT FOCUS for touchCARDIO
Listen to Dr. Anuradha Lala-Trindade discuss the burden of heart failure hospitalization, why inpatient intravenous diuresis remains the conventional approach to worsening heart failure, and how outpatient and home-based decongestion strategies, supported by appro…
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to an interview with Dr. Christine Kay on the role of vitamin A in the retina, how vitamin A processing is disrupted in Stargardt disease, and the mechanism of action, emerging clinical evidence, and key safety considerations for emerging oral therap…
touchIN CONVERSATION for touchNEUROLOGY and touchONCOLOGY
Management of neurofibromatosis type 1 (NF1)–associated plexiform neurofibromas in adults requires individualized decisions that account for symptoms, function, resectability and patient goals. Listen to NF1 experts Prof. Allan Belzberg, a …
Dr. Melinda Gooderham, Prof. Dr. Falk Bechara, and Dr. Daniel Stein discuss how evolving therapies are reshaping HS management and multidisciplinary care, with patient perspectives highlighting the impact of coordinated care and effective disease control.
The multidisciplinary team
Dr. Melinda …
अस्वीकरण: इस पृष्ठ पर एम्बेडेड पॉडकास्ट और कलाकृति touchpodcast से हैं, जो इसके मालिक की संपत्ति है और Listen Notes, Inc. से संबद्ध या समर्थित नहीं है।
संपादित करें
पॉडकास्ट डेटाबेस को अपडेटेड रखने में मदद के लिए धन्यवाद।
